# Junta clínica — PT-pseudo_ac1dc724676e (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_ac1dc724676e",
  "pid": "PT-pseudo_ac1dc724676e",
  "task": 1,
  "psa": 7.0,
  "age": 76,
  "months": 3,
  "pirads": "5",
  "psad": 0.07,
  "psav": 1.23,
  "psap": 6.0,
  "vol": 94.53,
  "dre": "Nodus",
  "bx": "Positive",
  "cspca": 0.7873657,
  "medhx": "Osteoarthritis",
  "meds": "paracetamol PRN",
  "notes": "PSA 7 ng/mL. PI-RADS 5. PSAD 0.07. Prostate volume 95 mL. DRE nodus. csPCa 0.79.",
  "pmhx": [
    "Osteoarthritis"
  ],
  "allergies": [],
  "vitals": {
    "weight": "96 kg",
    "height": "175 cm",
    "bmi": "31.3",
    "bp": "115/66 mmHg",
    "hr": "65 bpm",
    "smoking": "Non-smoker",
    "last_dental": "2 yr ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "26 Feb 2025",
  "enc_ref": "Dr. P. van Dijk (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical review requested after multiparametric MRI revealed a PI-RADS 5 lesion and earlier biopsy results returned Positive."
    },
    {
      "s": "History",
      "t": "Surveillance protocols and lower urinary tract symptom oversight have guided care for an extended period. He is a 76-year-old retired mechanical engineer, Widowed, and Lives with partner. A Non-smoker, he sustains a rigorous routine involving twenty-kilometre cycling sessions twice weekly, alongside a weekly alcohol intake of seven units. His lower urinary tract symptoms are pronounced, registering an IPSS score of 30 from 35. Concurrent osteoarthritis is managed with paracetamol PRN. Apart from a recent podiatry visit and a stable right knee, his systemic health remains unchanged with no new complaints reported."
    },
    {
      "s": "Physical examination",
      "t": "Nodus DRE: The prostate exhibits asymmetric enlargement with a firm, irregular nodule localized to the left peripheral zone. Abdominal and cardiovascular assessments yield normal results. Vital parameters remain steady at 115/66 mmHg, with a pulse of 65 beats per minute."
    }
  ],
  "occupation": "retired mechanical engineer",
  "marital": "Widowed",
  "living": "Lives with partner",
  "next_of_kin": "Sibling (brother)",
  "recent_other": [
    "Podiatry — routine foot care"
  ],
  "alcohol": "7 units / week",
  "exercise": "Cycling 2x/week, ~20 km",
  "ipss": "IPSS score: 30/35 (severe LUTS)",
  "admin": "Interpreter: not required. Consent for data use: signed.",
  "mri_hospital": "Ziekenhuis Gelderse Vallei (Ede)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_ac1dc724676e
Task: 1

Encounter: Urology - outpatient on 26 Feb 2025.
Referrer: Dr. P. van Dijk (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 76-year-old male
  - PSA: 7.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.07 ng/mL²
  - PSA velocity: 1.23 ng/mL/yr
  - Prior PSA: 6.0 ng/mL
  - Prostate volume: 94.53 mL
  - Months since last PSA: 3
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7873657 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Osteoarthritis
  - Problem list / PMHx: Osteoarthritis
  - Current medication: paracetamol PRN
  - Allergies: NKA
  - Additional notes: PSA 7 ng/mL. PI-RADS 5. PSAD 0.07. Prostate volume 95 mL. DRE nodus. csPCa 0.79.

Vitals: weight 96 kg, height 175 cm, BMI 31.3, BP 115/66 mmHg, HR 65 bpm. Smoking: Non-smoker.

Chief complaint: Clinical review requested after multiparametric MRI revealed a PI-RADS 5 lesion and earlier biopsy results returned Positive.

History: Surveillance protocols and lower urinary tract symptom oversight have guided care for an extended period. He is a 76-year-old retired mechanical engineer, Widowed, and Lives with partner. A Non-smoker, he sustains a rigorous routine involving twenty-kilometre cycling sessions twice weekly, alongside a weekly alcohol intake of seven units. His lower urinary tract symptoms are pronounced, registering an IPSS score of 30 from 35. Concurrent osteoarthritis is managed with paracetamol PRN. Apart from a recent podiatry visit and a stable right knee, his systemic health remains unchanged with no new complaints reported.

Physical examination: Nodus DRE: The prostate exhibits asymmetric enlargement with a firm, irregular nodule localized to the left peripheral zone. Abdominal and cardiovascular assessments yield normal results. Vital parameters remain steady at 115/66 mmHg, with a pulse of 65 beats per minute.

Patient info: retired mechanical engineer; Widowed; Lives with partner.
Next of kin: Sibling (brother).

Lifestyle: alcohol 7 units / week; exercise Cycling 2x/week, ~20 km; IPSS score: 30/35 (severe LUTS).

Recent other appointments: Podiatry — routine foot care.
Admin: Interpreter: not required. Consent for data use: signed.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.42
  uncertainty  +/- 0.11 epistemic (95% band 0.21-0.64); among patients I cannot tell apart the outcome was 0.98 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 1 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 76 (2% of my signal; from age) · DRE = Nodus (10% of my signal; from dre_suspicious) · PSA = 7 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 94.53 mL (1% of my signal; from log_vol, vol) · PSA density = 0.07 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.79 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 76 · DRE = Nodus · PSA = 7 ng/mL · prostate volume = 94.53 mL · PSA density = 0.07 · PI-RADS = 5 · comorbidity = 1 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.46: PI-RADS 5, PSA 4.2, PSAD 0.06, age 67, DRE Nodus -> DEFER (uncertain). He wrote: "Need to know if the lesion has grown or if it is stabile."
  2. distance 1.82: PI-RADS 5, PSA 8.6, PSAD 0.202, age 68, DRE Nodus -> BIOPSY (clear). He wrote: "Patient reasonable to discuss curative treatment with (age 68, no very dramatic comorbidity, unfavorable intermediate risk disease). Considering he chose not curative tr…"
  3. distance 1.82: PI-RADS 5, PSA 6.9, PSAD 0.171, age 67, DRE Nodus -> DEFER (borderline). He wrote: "Need to know if the P5 lesion has grown in size. If not no biopsy."

PRECEDENT: DEFER (weighted vote 0.31 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · DRE = Nodus · PSA = 7 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · age = 76 · prostate volume = 94.53 mL · PSA density = 0.07 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 76 · DRE = Nodus · PSA = 7 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · prostate volume = 94.53 mL · PSA density = 0.07 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guideline discusses using a risk-adapted pathway based on PI-RADS score, PSA density, and prior biopsy status. "Applying a PSA-D cut-off of 0.15ng/mL/cc, 817 biopsy procedures (58.4%) would have been avoided, at the cost of missing ISUP GG 2 cancer in 91 men (6.5%), while ISUP GG 1 cancer would not have been detected in 115 men (8.2%) [385]."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your variable 'prior biopsy = Positive' is decisive, whereas the guideline treats it as context; the guideline requires the documented grade of the prior biopsy to determine the next step. The guideline needs the documented prior biopsy grade, which no panel variable represents.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trajectory: the guideline requires this to assess risk in conjunction with other factors
laboratory_results - the PSA density: the guideline uses this in conjunction with PI-RADS score to guide the decision

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges entirely on the documented grade of the prior biopsy and the PSA trajectory, as the current panel is inconclusive.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the lesion size or status compared against an earlier study support re-sampling?
  psa_trend (get_psa_trend) -> What is the PSA trajectory?
  previous_notes (get_previous_notes) -> What is the documented grade of the prior biopsy, and is there a surveillance protocol with a confirmatory biopsy due?
  laboratory_results (get_lab_results) -> What is the PSA density?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?
  Q2. What is the PSA trajectory?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report: Subject: Multiparametric MRI Prostate. The lesion size or status compared against an earlier study is described as a "discrete hypointense focus within the left peripheral zone, spanning from the base toward the mid-gland at roughly 18 mm."
psa_trend: The PSA trajectory shows a rise from "2.5 ng/mL (Feb 2024)" to "7.0 ng/mL (Feb 2025)," indicating a rising trend.
previous_notes: The documented grade of the prior biopsy is "Positive," and there is "no surveillance protocol with a confirmatory biopsy due."
laboratory_results: The PSA density is "0.07 ng/mL/mL."

WHAT I DID NOT OPEN
family-history anamnesis, because the documented prior biopsy grade and PSA trajectory are more immediately relevant to the decision.

WHAT THIS SUPPORTS
FOR sampling this patient now:
- radiology_report: The finding of a "PI-RADS 5 lesion" and a lesion size of "roughly 18 mm" suggests high concern.
- psa_trend: The PSA trajectory shows a clear rise from "2.5 ng/mL (Feb 2024)" to "7.0 ng/mL (Feb 2025)."

AGAINST sampling this patient now:
- previous_notes: There is "no surveillance protocol with a confirmatory biopsy due," suggesting current surveillance is not formally mandated by protocol.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 7.00 ng/mL over 4 points spanning 12 months; velocity +4.50 ng/mL per year; doubling time about 8 months.
PROJECTION at 6 months: 10.3 ng/mL, conformal 95% band 2.9-35.8.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 7 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: NO BIOPSY   p(biopsy) = 0.46
  uncertainty  +/- 0.11 epistemic (95% band 0.24-0.68), of which 0.00 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Nodus (5% of my signal; from dre_suspicious) · PSA = 7 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 94.53 mL (4% of my signal; from log_vol, vol) · PSA density = 0.07 (0% of my signal; from psad_calc) · comorbidity = 1 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.42  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      DEFER, p(biopsy)=0.46  ('discuss' tier, fusion_full; weight 1.5)
  EXPERT-LIBRARY     DEFER, p(biopsy)=0.31  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.45 — carried by weighted panel.
PANEL ANSWER: NO BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          76                           E1:not E3:— cohort:not library:not E2:—              -> important
  dre          Nodus                        E1:not E3:not cohort:not library:IMP E2:—            -> important
  psa          7 ng/mL                      E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          94.53 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.07                         E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.79                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  1 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: borderline.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes, laboratory_results) have addressed the moderator's questions to some extent. The `previous_notes` explicitly state the prior biopsy was "Positive" and there is "no surveillance protocol with a confirmatory biopsy due," answering Q1 partially. The `psa_trend` answers Q2 by showing a rise from "2.5 ng/mL (Feb 2024)" to "7.0 ng/mL (Feb 2025)."

ALIGNMENT WITH THE PANEL
The retrieved evidence, specifically the rising PSA trend and the lack of a surveillance protocol, leans towards the panel's decision of NO BIOPSY, as the guideline suggests that if the prior grade is unrecorded, the indication stands, and the rising PSA is a factor. The panel's decision rests on the lack of a documented prior grade.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? Answered by the `previous_notes`: "Positive."
Q2. What is the PSA trajectory? Answered by the `psa_trend`: A rising trend from 2.5 ng/mL to 7.0 ng/mL.

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: Positive (noted) because the `previous_notes` state the documented grade is "Positive," which is a key factor the panel noted as 'decisive'. I would move this to 'important' as it is a known fact, not just a panel variable. <psa>: Rising (important) because the `psa_trend` shows a clear rise, which Expert-PSA noted as borderline, suggesting the disease is active. My confidence in the record as it stands is clear, as all documents listed by the trace model were opened.

MY SUGGESTION TO THE CHAIR
The record is ready for a decision based on the retrieved facts. Given the rising PSA and the lack of a formal surveillance protocol, I suggest proceeding with a biopsy to establish the current pathological status, as the guideline suggests the indication stands if the prior grade is unrecorded.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: NO BIOPSY   (confidence: borderline)

Age 76, PSA 7.0 ng/mL, PI-RADS 5, and prior positive biopsy without documented grade suggest disease characterization. The PI-RADS 5 finding pulls toward biopsy, but the lack of prior biopsy grade prevents definitive risk stratification. Re-image in two years with a low threshold for biopsy is the alternative plan.

What carried weight: bx=important, age=important, dre=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
